Oral acetazolamide or thiazide therapy in addition to furosemide for volume control in patients recently discharged with heart failure (ACTHIVOL trial)

12 May 2026 (08:30 - 10:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - implantable cardioverter-defibrillator Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)